Orange Book product · Brand (NDA)
KONVOMEP
OMEPRAZOLE; SODIUM BICARBONATE
At a glance
Aug 30, 2022
Approved
Brand (NDA)
Application
Not listed
TE code
9
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 30, 2022
3 yr 10 mo ago
Today
Patent 10751333 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 11103492 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 11633478 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 11911473 expires
Listed method-of-use patent (U-623) expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 11911473 expires
Listed method-of-use patent (U-624) expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 12042539 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 12329752 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 12440566 expires
Listed drug product patent expiration.
Jul 16, 2039
in 13 yr 3 mo
Patent 11771686 expires
Listed method-of-use patent (U-623) expiration.
Mar 01, 2040
in 13 yr 11 mo
Pharmaceutical detail
Active ingredient
OMEPRAZOLE; SODIUM BICARBONATE
Strength
2MG/ML;84MG/ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 213593
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2013ZEGERID OTCBrand (NDA)
NDA 022283 · RILEY CONSUMER
- 2009ZEGERID OTCBrand (NDA)
NDA 022281 · RILEY CONSUMER
- 2006ZEGERIDBrand (NDA)
NDA 021849 · SALIX
- 2004ZEGERIDBrand (NDA)
NDA 021636 · SALIX
- 2025OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 219161 · NOVITIUM PHARMA
- 2024OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 217784 · DR REDDYS
- 2020OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 212587 · ANDA REPOSITORY
- 2018OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 203290 · ZYDUS PHARMS
- 2018OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 203345 · ZYDUS
- 2016OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 207476 · SCIEGEN PHARMS
- 2016OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 204923 · AUROBINDO PHARMA
- 2016OMEPRAZOLE AND SODIUM BICARBONATEGeneric (ANDA)
ANDA 204922 · AUROLIFE PHARMA LLC
Listed patents (9)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10751333 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 11103492 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 11633478 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 11911473 | Jul 16, 2039 | in 13 yr 3 mo | U-623 |
| 11911473 | Jul 16, 2039 | in 13 yr 3 mo | U-624 |
| 12042539 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 12329752 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 12440566 | Jul 16, 2039 | in 13 yr 3 mo | Product |
| 11771686 | Mar 01, 2040 | in 13 yr 11 mo | U-623 |

